Manage your account, request prescriptions, set up appointments & more.

Don't have an account
Contact Us

Cancer Clinical Trials

Clinical trials are research studies that involve people. Cancer clinical trials are designed to answer questions about new ways to diagnose, treat and prevent cancer. They might also help to better manage symptoms of cancer.

If you have been diagnosed with cancer and are interested in learning about clinical trials available at Legacy Health, please speak with your doctor. It’s important that you understand the various treatment options that might be available to you. Here’s why:

  • Clinical trials may only be available at certain locations
  • You might be a possible candidate for a clinical trial, so it's important to have a doctor who is part of a cancer program or health care system that offers trials

Open clinical trials

Below are some of the Legacy Cancer Institute trials open to patients. If you are interested in participating in a trial, talk with your doctor or contact Legacy Oncology Clinical Research for more information: 503-413-8199.

Featured trial: Breast cancer 

A new clinical trial that could prevent recurrence in women who have survived triple negative breast cancer or who have had lymph node involvement:  Legacy Good Samaritan is one of only 20 hospitals across the United States to take part in the study and the only one in the Pacific Northwest.

This research trial combines Herceptin, a drug that is used to treat other types of breast cancer, and E75, a peptide-based vaccine aimed at preventing or delaying the recurrence of breast cancer in cancer survivors who achieve remission after surgery, radiation, and chemotherapy.

Eligibility criteria

  • Legacy Cancer Institute patients who are disease-free and recently completed the standard course of treatment at Legacy Good Samaritan Medical Center, including surgery from Legacy Medical Group—Surgical Oncology
  • Diagnosed with triple negative or lymph-node positive breast cancer of any subtype
  • Women 18 and older


Learn more.